OverviewSuggest Edit

Cryoport delivers a complete outsourced frozen shipping solution for biological materials. This combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. We combine the technology of liquid nitrogen dry vapor shippers with the most advanced Logistics Management Platform in the industry. The Company provides a complete outsourced solution that advances deep-frozen shipping for the life science community.
HQIrvine, CA, US
Employee Ratings3.5

Latest Updates

Employees (est.) (Dec 2019)105(+15%)
Job Openings17
Revenue (FY, 2020)$78.7 M(+132%)
Share Price (Apr 2021)$51.3
Cybersecurity ratingBMore

Key People/Management at Cryoport

Jerrell W. Shelton

Jerrell W. Shelton

President and Chief Executive Officer, Chairman
Robert S. Stefanovich

Robert S. Stefanovich

Chief Financial Officer, Treasurer and Corporate Secretary
Mark W. Sawicki

Mark W. Sawicki

President and Chief Executive Officer
Bret Bollinger

Bret Bollinger

Chief Technology Officer
Thomas J. Heinzen

Thomas J. Heinzen

Vice President of Corporate Development
Phil Wilson

Phil Wilson

Senior Vice President of Global Operations & Supply Chain
Show more

Cryoport Office Locations

Cryoport has offices in Irvine, Brentwood and Livingston
Irvine, CA, US (HQ)
17305 Daimler St
Brentwood, TN, US
112 Westwood Pl #350
Livingston, NJ, US
7 Industrial Pkwy #27
Show all (3)

Cryoport Financials and Metrics

Cryoport Revenue

Embed Graph
View revenue for all periods
Cryoport's revenue was reported to be $78.7 m in FY, 2020

Revenue (FY, 2020)


Gross profit (FY, 2020)


Gross profit margin (FY, 2020), %


Net income (FY, 2020)


EBIT (FY, 2020)


Market capitalization (7-Apr-2021)


Closing stock price (7-Apr-2021)


Cash (31-Dec-2020)



Cryoport's current market capitalization is $2.3 b.
USDQ1, 2012

Financial Leverage

2.1 x
Show all financial metrics

Cryoport Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Cryoport Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset


out of 100

CSRHub logo

Cryoport Online and Social Media Presence

Embed Graph

Cryoport News and Updates

Can CryoPort Stock Rebound After A Recent 22% Drop?

The stock price of CryoPort, a provider of cold chain logistics solutions for biopharmaceutical companies, has seen a large 22% drop over the last five trading days, but we believe the stock, after the recent drop, may trend higher in the near term. The recent drop can largely be attributed to...

Cryoport to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 1, 2021

NASHVILLE, Tenn., Feb. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the fourth...

Cryoport Reports 2020 Third-Quarter Results

NASHVILLE, Tenn., Nov. 5, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport", "our" or "we"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced financial results for the Third Quarter and nine-month period ended...

Chart Industries Signs Definitive Agreement to Divest Cryobiological Products Business for $320 Million to Cryoport, Inc.

ATLANTA, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (“Chart”) (NASDAQ: GTLS) today announced that it has signed a definitive agreement to divest its cryobiological products business (MVE Biological Products) within the Distribution & Storage Western Hemisphere (“D&S West”) se…

Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP

NASHVILLE, Tenn., Aug. 21, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the expansion of its global supply chain network and services by...

Cryoport to Report Third Quarter 2019 Financial Results on November 7, 2019

IRVINE, Calif., Oct. 31, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced that the Company will report financial results...
Show more

Cryoport Blogs

Cryoport Systems Now Supporting 7 Commercial Therapies Globally

We’re celebrating big news from two Cryoport Systems valued clients: bluebird bio and Bristol Myers-Squibb announced FDA approval of their cell therapy Abecma, a personalized immune therapy for patients with multiple myeloma.

More Commercial Activity, More Commercial Filings: Good News Ahead for Regenerative Medicine

While the pandemic continues to disrupt many industries, including regenerative medicine, it’s not all bad news -- in fact, there are likely some bright spots ahead for the industry this year.

Forbes Honors Cryoport, Inc. on 2021 ‘100 Best Small Companies’ List

2020 was an incredible year of growth for Cryoport, Inc. The acquisitions of CRYOPDP and MVE Biological Solutions dramatically increased our global network and capabilities, and we achieved a new record of supporting over 500 clinical trials worldwide. During a calamitous year in which t…

Now That A Brexit Deal Has Been Negotiated, Here Is What Cryoport Clients Can Expect

Background information: On January 31, 2020, the United Kingdom (UK) officially withdrew from the European Union (EU).   An eleven-month transition period was enacted to negotiate trade terms between the UK and the EU, and this transition period expires on December 31, 2020.

Cryoport Client Informational Bulletin: Brexit

The Brexit transition period is set to expire on December 31, 2020. If you have questions regarding possible outcomes and effects on transporting goods across international borders, please review the following.  

Cryoport, Inc. By The Numbers: A Year of Record Expansion in 2020

The events of 2020 put unprecedented pressures on the pharmaceutical and logistics industries. As the pandemic lobbed one challenge after the next – cancelled flights, limited flight cargo space, waves of international and domestic lockdowns – supply chains all over the world were thrown…
Show more

Cryoport Frequently Asked Questions

  • When was Cryoport founded?

    Cryoport was founded in 1990.

  • Who are Cryoport key executives?

    Cryoport's key executives are Jerrell W. Shelton, Robert S. Stefanovich and Mark W. Sawicki.

  • How many employees does Cryoport have?

    Cryoport has 105 employees.

  • What is Cryoport revenue?

    Latest Cryoport annual revenue is $78.7 m.

  • What is Cryoport revenue per employee?

    Latest Cryoport revenue per employee is $749.5 k.

  • Who are Cryoport competitors?

    Competitors of Cryoport include PeriShip, DRT Transportation and Vitran.

  • Where is Cryoport headquarters?

    Cryoport headquarters is located at 17305 Daimler St, Irvine.

  • Where are Cryoport offices?

    Cryoport has offices in Irvine, Brentwood and Livingston.

  • How many offices does Cryoport have?

    Cryoport has 3 offices.